102 related articles for article (PubMed ID: 25847737)
1. [Accumulation of p53 protein and overexpression of the HER3 receptor in colorectal cancer].
Amsaguine S; El Mhaia S; Drissi H; Amer C; Ahallat M; El Amrani N; Radallah D
Ann Biol Clin (Paris); 2015; 73(2):158-64. PubMed ID: 25847737
[TBL] [Abstract][Full Text] [Related]
2. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of p53 and c-erbB-2 immunohistochemical evaluation in colorectal adenocarcinoma.
Lazaris AC; Theodoropoulos GE; Anastassopoulos P; Nakopoulou L; Panoussopoulos D; Papadimitriou K
Histol Histopathol; 1995 Jul; 10(3):661-8. PubMed ID: 7579815
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas.
Bosari S; Viale G; Bossi P; Maggioni M; Coggi G; Murray JJ; Lee AK
J Natl Cancer Inst; 1994 May; 86(9):681-7. PubMed ID: 8158699
[TBL] [Abstract][Full Text] [Related]
5. Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma.
Chang SC; Lin JK; Lin TC; Liang WY
Int J Oncol; 2005 Jan; 26(1):65-75. PubMed ID: 15586226
[TBL] [Abstract][Full Text] [Related]
6. Expression of c-erbB-2 and p53 in colorectal adenocarcinoma.
Sun XF; Carstensen JM; Nordenskjöld B
Anal Cell Pathol; 1995 Apr; 8(3):203-11. PubMed ID: 7547494
[TBL] [Abstract][Full Text] [Related]
7. HER3 overexpression and survival in solid tumors: a meta-analysis.
Ocana A; Vera-Badillo F; Seruga B; Templeton A; Pandiella A; Amir E
J Natl Cancer Inst; 2013 Feb; 105(4):266-73. PubMed ID: 23221996
[TBL] [Abstract][Full Text] [Related]
8. Prognostic evaluation of CD44 expression in correlation with bcl-2 and p53 in colorectal cancer.
Zavrides HN; Zizi-Sermpetzoglou A; Panousopoulos D; Athanasas G; Elemenoglou I; Peros G
Folia Histochem Cytobiol; 2005; 43(1):31-6. PubMed ID: 15871560
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of HER3 and HER4 protein expression in colorectal adenocarcinomas.
Kountourakis P; Pavlakis K; Psyrri A; Rontogianni D; Xiros N; Patsouris E; Pectasides D; Economopoulos T
BMC Cancer; 2006 Feb; 6():46. PubMed ID: 16507107
[TBL] [Abstract][Full Text] [Related]
10. Expression of p16INK4a, alone or combined with p53, is predictive of better prognosis in colorectal adenocarcinoma in Tunisian patients.
Miladi-Abdennadher I; Abdelmaksoud-Damak R; Ayadi L; Khabir A; Amouri A; Frikha F; Ellouz S; Frikha M; Sellami-Boudawara T; Mokdad-Gargouri R
Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):562-8. PubMed ID: 22095233
[TBL] [Abstract][Full Text] [Related]
11. p53 and CD44 as clinical markers of tumour progression in colorectal carcinogenesis.
Mulder JW; Wielenga VJ; Pals ST; Offerhaus GJ
Histochem J; 1997 Jun; 29(6):439-52. PubMed ID: 9248852
[TBL] [Abstract][Full Text] [Related]
12. Influence of tumor localization on the prognostic value of P53 protein in colorectal adenocarcinomas.
Diez M; Medrano M; Mugüerza JM; Ramos P; Hernandez P; Villeta R; Martín A; Noguerales F; Ruiz A; Granell J
Anticancer Res; 2000; 20(5C):3907-12. PubMed ID: 11268475
[TBL] [Abstract][Full Text] [Related]
13. [A comparative study on the prognostic value of the nuclear expression of protein p53 vis-à-vis histopathology in colorectal cancer].
Díez M; Camuñas J; Enríquez JM; González A; Torabuela E; Gutiérrez A; Ratia T; Mugüerza JM; Martín A; Ruiz A; Granell J
An Med Interna; 1996 May; 13(5):222-6. PubMed ID: 8767868
[TBL] [Abstract][Full Text] [Related]
14. Clinico-pathological correlation and prognostic significance of nuclear p53 protein in colorectal cancer. Colorectal Cancer Study Group of the University and Health Care District of Modena.
Fante R; Di Gregorio C; Losi L; Roncucci L; Ponz de Leon M
Ital J Gastroenterol; 1996 May; 28(4):205-10. PubMed ID: 8842835
[TBL] [Abstract][Full Text] [Related]
15. Does p53 overexpression cause metastases in early invasive colorectal adenocarcinoma?
Sory A; Minamoto T; Ohta T; Yamashita K; Sawaguchi K; Mai M; Misiuna P
Eur J Surg; 1997 Sep; 163(9):685-92. PubMed ID: 9311476
[TBL] [Abstract][Full Text] [Related]
16. Nuclear accumulation of p53 in colorectal adenocarcinoma: prognostic importance differs with race and location of the tumor.
Manne U; Weiss HL; Myers RB; Danner OK; Moron C; Srivastava S; Grizzle WE
Cancer; 1998 Dec; 83(12):2456-67. PubMed ID: 9874449
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study.
Langer R; Von Rahden BH; Nahrig J; Von Weyhern C; Reiter R; Feith M; Stein HJ; Siewert JR; Höfler H; Sarbia M
J Clin Pathol; 2006 Jun; 59(6):631-4. PubMed ID: 16731604
[TBL] [Abstract][Full Text] [Related]
18. An immunohistochemical study of P53 protein on colorectal carcinomas.
Pandrea IV; Mihailovici MS; Carasevici E; Székely AM; Reynes M; Târcoveanu E; Dragomir C
Rev Med Chir Soc Med Nat Iasi; 1995; 99(3-4):171-8. PubMed ID: 9455363
[TBL] [Abstract][Full Text] [Related]
19. Estimation of tumor stage and lymph node status in patients with colorectal adenocarcinoma using probabilistic neural networks and logistic regression.
Singson RP; Alsabeh R; Geller SA; Marchevsky A
Mod Pathol; 1999 May; 12(5):479-84. PubMed ID: 10349985
[TBL] [Abstract][Full Text] [Related]
20. [Immunohistochemical detection of p53 in colorectal cancer and its relationship to prognosis].
Yamaguchi A; Fushida S; Kurosaka Y; Kanno M; Yonemura Y; Miyazaki I
Nihon Geka Gakkai Zasshi; 1992 Oct; 93(10):1312-6. PubMed ID: 1435694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
